NCT03529383

Brief Summary

The 3-year DISCO study aims to systematically implement physical activity in breast cancer patients. The primary objective is to investigate the efficacy of a connected device (personalized non-supervised exercise program including a wristband as activity tracker, a smartphone application, and a website) and the efficacy of a therapeutic education program on the physical activity level of patients at the end of the 6-month programs. The research hypothesis is that patients participating in the intervention with the connected device or in the therapeutic education program will achieve the international recommendations in terms of physical activity, compared to women receiving only physical activity recommendations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
436

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started May 2018

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 18, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

May 18, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2022

Completed
Last Updated

March 22, 2023

Status Verified

July 1, 2022

Enrollment Period

3.8 years

First QC Date

April 13, 2018

Last Update Submit

March 21, 2023

Conditions

Keywords

Localized breast cancerExerciseAdapted physical activitySedentaryConnected deviceActivity trackersTherapeutic educationObesity

Outcome Measures

Primary Outcomes (1)

  • Number of patients achieving the internationally recommended level of physical activity of at least 150 minutes per week of moderate-to-vigorous physical activity (intensity ≥3 METs)

    Assessed by the RPAQ self-administered questionnaire

    6 months

Secondary Outcomes (28)

  • Number of patients achieving the internationally recommended level of physical activity of at least 150 minutes per week of moderate-to-vigorous physical activity (intensity ≥3 METs)

    12 months

  • Proportion of patients who are compliant to the programs

    6 months

  • Proportion of patients who change their physical activity profile (Time spent in different intensities of physical activity, time spent in sedentary activities)

    Change between baseline and 6 months and between 6 months and 12 months

  • Proportion of patients who change their physical condition (6-min walking test)

    Change between baseline and 6 months and between 6 months and 12 months

  • Proportion of patients who change their physical condition (Sit to stand test)

    Change between baseline and 6 months and between 6 months and 12 months

  • +23 more secondary outcomes

Other Outcomes (3)

  • Cost-utility of the interventions as assessed using clinical data (treatments received, patients' diary on medical consultations) and hospital costs (national data).

    12 months

  • Cost-effectiveness of the interventions as assessed using clinical data (treatments received, patients' diary on medical consultations), hospital costs (national data), and benefit in physical activity level.

    12 months

  • Assessment of the association between the objective and subjective characteristics of living spaces and patients' PA practices.

    12 months

Study Arms (4)

Connected device

EXPERIMENTAL

Women randomized to the "connected device" arm will follow a 6-month exercise program using a connected device that includes an activity tracker and subscription to an exercise and physical activity management program through a smartphone application and a website. They will also receive international recommendations on physical activity.

Device: Connected device

Therapeutic education

EXPERIMENTAL

Women randomized to the "therapeutic education" arm will follow a 6-month program of therapeutic patient education. They will also receive international recommendations on physical activity.

Behavioral: Therapeutic education

Combined

EXPERIMENTAL

Women will benefit from both the "connected device" intervention and the "therapeutic education" intervention and receive international recommendations on physical activity.

Device: Connected deviceBehavioral: Therapeutic education

Control

NO INTERVENTION

Women will receive standard care, i.e., international recommendations on physical activity, without further intervention.

Interventions

Women will receive a connected wristband (https://www.carefitness.com/) and a subscription to a smartphone application and website (http://disco.biomouv.com/). They will have to participate in a 6-month personalized non-supervised exercise program consisting of 3 weekly sessions of 20 min to 1-hr of moderate-to-vigorous physical activity (≥3 METs): 2 sessions of brisk walking and 1 session of muscle strengthening. Women should wear the wristband daily to track their number of steps (automatic Bluetooth synchronization to the application). Duration and intensity of sessions and target number of daily steps will progressively increase (+15% up to 10,000 steps) to place the patients in a progression dynamic. Women will receive phone-based follow-up at 1 week, 2 months, and 4 months.

CombinedConnected device

Women will be invited to participate in the 6-month therapeutic patient education program "Mieux manger, mieux bouger" ("Eat better, move better") elaborated at the Léon Bérard cancer center. The program consists in four sessions: * a 1-hour individual session of "educational diagnosis" to assess their needs and establish a contract of objectives, * two "educational sessions" of 1h30 each using tools, in group of 10 patients maximum to improve their daily practice of physical activity, * a 1-hour individual session of "educational assessment" to evaluate whether their objectives were reached.

CombinedTherapeutic education

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female between 18 and 75 years old,
  • Being diagnosed with a first primary non-metastatic invasive breast carcinoma, that has been histologically confirmed,
  • Having been operated and requiring the prescription of an adjuvant treatment (chemotherapy, hormonotherapy, radiotherapy),
  • Whose adjuvant treatment will be prescribed (for hormone therapy) or carried out (for chemotherapy and radiotherapy) in one of the investigating centers,
  • Being able to practice adapted physical activity and providing a medical certificate of no contraindications to exercise issued by the investigator physician, the general practitioner, or the referring physician,
  • Available and willing to participate in the study for the duration of the interventions and follow-up,
  • Using a personal smartphone compatible with the application (iOS operating system from version 9.3, Android operating system from version 5.0, no Microsoft operating system) and having Internet access on a computer,
  • Able to understand, read, and write French,
  • Affiliated with a social security scheme,
  • Having dated and signed an informed consent.

You may not qualify if:

  • Woman with recurrent, metastatic, or inflammatory breast cancer,
  • Personal history or co-existence of another primary cancer (except of in situ cancer regardless of the site and/or basal cell skin cancer and/or non-mammary cancer in complete remission for more than 5 years),
  • Presenting a contraindication to exercise according to the investigator (such as cardiorespiratory or bone pathologies, non-stabilized chronic diseases such as diabetes, malnutrition, etc.),
  • In a state of severe malnutrition according to the criteria of the French National Health Authority (i.e., in women ≤ 70 years: weight loss ≥ 15% in 6 months or ≥ 10% in 1 month; in women \> 70 years: weight loss ≥ 15% in 6 months or ≥ 10% in 1 month, and body mass index \< 18 kg/m²),
  • Unable to be followed for medical, social, family, geographic or psychological reasons for the duration of the study,
  • Participating in simultaneous physical activity studies,
  • Deprived of their liberty by court or administrative decision,
  • Pregnant or breastfeeding or of childbearing age without effective contraception for the duration of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Institut Sainte-Catherine

Avignon, France

Location

CHRU Besançon

Besançon, France

Location

Centre Léon Bérard

Lyon, 69008, France

Location

Related Publications (11)

  • Beasley JM, Kwan ML, Chen WY, Weltzien EK, Kroenke CH, Lu W, Nechuta SJ, Cadmus-Bertram L, Patterson RE, Sternfeld B, Shu XO, Pierce JP, Caan BJ. Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project. Breast Cancer Res Treat. 2012 Jan;131(2):637-43. doi: 10.1007/s10549-011-1770-1. Epub 2011 Sep 21.

    PMID: 21935600BACKGROUND
  • Beg MS, Gupta A, Stewart T, Rethorst CD. Promise of Wearable Physical Activity Monitors in Oncology Practice. J Oncol Pract. 2017 Feb;13(2):82-89. doi: 10.1200/JOP.2016.016857.

    PMID: 28387544BACKGROUND
  • Cadmus-Bertram LA, Marcus BH, Patterson RE, Parker BA, Morey BL. Randomized Trial of a Fitbit-Based Physical Activity Intervention for Women. Am J Prev Med. 2015 Sep;49(3):414-8. doi: 10.1016/j.amepre.2015.01.020. Epub 2015 Jun 10.

    PMID: 26071863BACKGROUND
  • Ferguson T, Rowlands AV, Olds T, Maher C. The validity of consumer-level, activity monitors in healthy adults worn in free-living conditions: a cross-sectional study. Int J Behav Nutr Phys Act. 2015 Mar 27;12:42. doi: 10.1186/s12966-015-0201-9.

    PMID: 25890168BACKGROUND
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.

    PMID: 25220842BACKGROUND
  • Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011 Sep;28(3):753-65. doi: 10.1007/s12032-010-9536-x. Epub 2010 Apr 22.

    PMID: 20411366BACKGROUND
  • Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015 May;54(5):635-54. doi: 10.3109/0284186X.2014.998275. Epub 2015 Mar 9.

    PMID: 25752971BACKGROUND
  • Sullivan AN, Lachman ME. Behavior Change with Fitness Technology in Sedentary Adults: A Review of the Evidence for Increasing Physical Activity. Front Public Health. 2017 Jan 11;4:289. doi: 10.3389/fpubh.2016.00289. eCollection 2016.

    PMID: 28123997BACKGROUND
  • Thariat J, Creisson A, Chamignon B, Dejode M, Gastineau M, Hebert C, Boissin F, Topfer C, Gilbert E, Grondin B, Guennoc H, Mari V, Buzzo S, Saja D, Duboue N, Boulahssass R, Tosi A, Verne S, Ducray J, Benard-Thiery I, Ferrero JM. [Integrating patient education in your oncology practice]. Bull Cancer. 2016 Jul-Aug;103(7-8):674-90. doi: 10.1016/j.bulcan.2016.04.007. Epub 2016 Jun 7. French.

    PMID: 27286758BACKGROUND
  • Tudor-Locke C, Hatano Y, Pangrazi RP, Kang M. Revisiting "how many steps are enough?". Med Sci Sports Exerc. 2008 Jul;40(7 Suppl):S537-43. doi: 10.1249/MSS.0b013e31817c7133.

    PMID: 18562971BACKGROUND
  • Touillaud M, Fournier B, Perol O, Delrieu L, Maire A, Belladame E, Perol D, Perrier L, Preau M, Leroy T, Fassier JB, Fillol F, Pascal S, Durand T, Fervers B. Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2x2 factorial randomised controlled trial. BMJ Open. 2021 Sep 13;11(9):e045448. doi: 10.1136/bmjopen-2020-045448.

MeSH Terms

Conditions

Breast NeoplasmsMotor ActivitySedentary BehaviorObesity

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Béatrice Fervers, MD, PhD

    Centre Léon Bérard, Lyon, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: Two interventions, each alone and in combination, are evaluated in parallel against a control group. Women assigned to the "connected device" arm will follow a 6-month exercise program using a connected device. Women assigned to the "therapeutic education" arm will follow a 6-month program of therapeutic patient education in physical activity. Women assigned to the "combined" arm will follow both programs. Women assigned to the "control" arm will receive international recommendations on physical activity.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2018

First Posted

May 18, 2018

Study Start

May 18, 2018

Primary Completion

March 4, 2022

Study Completion

September 23, 2022

Last Updated

March 22, 2023

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations